HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Mocci Selected Research

myelin basic protein 84-102

4/2000A phase I trial of solubilized DR2:MBP84-102 (AG284) in multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Mocci Research Topics

Disease

2Autoimmune Diseases (Autoimmune Disease)
12/2000 - 10/2000
2Multiple Sclerosis
10/2000 - 04/2000
1Edema (Dropsy)
09/2015
1Triple Negative Breast Neoplasms
09/2015

Drug/Important Bio-Agent (IBA)

1Bevacizumab (Avastin)FDA Link
09/2015
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
09/2015
1onartuzumabIBA
09/2015
1Paclitaxel (Taxol)FDA LinkGeneric
09/2015
1AutoantigensIBA
12/2000
1Insulin (Novolin)FDA Link
10/2000
1ChemokinesIBA
10/2000
1myelin basic protein 84-102IBA
04/2000